News
-
EP PerMed CONNECT: Innovation Meets Implementation
From 30 September to 01 October 2026, EP PerMed will host an event focusing on reverse tech transfer entitled EP PerMed CONNECT: Innovation Meets Implementation. Limited seats are available.
-
New EP PerMed Report Explores Public Awareness and Perceptions of Personalised Medicine
EP PerMed has published a new report presenting the first results of its multilingual survey on public awareness, perceptions, expectations and concerns regarding Personalised Medicine (PM). The findings provide a baseline for understanding how people perceive personalised medicine and highlight important priorities for communication, engagement, trust and equitable access.
-
New Regional Funding Opportunities for Digital Health
Two new funding opportunities of interest to the personalised medicine community have recently been launched or announced through the UNITE and SYSTEMEU initiatives. The calls support the development and implementation of digital health solutions across Europe.
-
Health-NCP-Net 3.0 Publishes Guide to Health Funding Opportunities Across Horizon Europe
Health-NCP-Net 3.0 (HNN 3.0) has published ‘Health research and innovation funding opportunities across Horizon Europe with deadlines from September to December 2026’. The guide brings together health-related opportunities from the 2026-2027 Horizon Europe Work Programmes across all three pillars, extending beyond Cluster 1: Health.
Showcasing Impactful Research and Collaborations in Personalised Medicine
The EP PerMed success stories highlight the remarkable achievements and outcomes of projects funded under EP PerMed & ERA PerMed. These stories demonstrate the tangible impact of research in personalised medicine, from groundbreaking scientific discoveries to advancements in clinical practice, innovative methodologies, and collaborations that drive progress in healthcare.
Citizen Awareness of Personalised Medicine
Your opinion matters!

Have you been involved in a personalised treatment or are you aware of personalised medicine approaches?
EP PerMed likes to understand how well people are informed about personalised medicine, how they perceive it, and their thoughts on its potential benefits and challenges.
The anonymous survey contains 36 questions and takes approximately 10-15 minutes to complete. It is currently available in: English, Czech, Danish, Finnish, French, German, Greek, Italian, Norwegian, Dutch, Polish, Portuguese, Romanian, Spanish, Swedish and Turkish.
Mission & Objectives
EP PerMed Podcast ‘The Science of You’

The second season of the EP PerMed podcast tells four powerful stories of patients and former patients who have benefited from personalised medicine. With topics ranging from oncology and rare genetic disorders to preventive surgery and cardiovascular diseases, this season illustrates real human experiences, showing how tailored therapies are transforming the treatment process into a more effective and informed one.